Latest news

Commercial

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Asieris, a China-based company, has agreed to pay up to $250 million to get the first-in-class, non-surgical treatment for...
Clinical

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

MimiVax’s cancer vaccine failed to meet the primary endpoint in a phase 2b trial in newly diagnosed glioblastoma, but...
Clinical

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Cerevance reported positive topline results from its Phase 3 ARISE trial, showing that its oral investigational therapy solengepras reduced...
Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration (FDA) has identified four deaths among patients treated with its...
Manufacturing

BD Plans Huge U.S. Investment to Expand Medical Manufacturing

BD is preparing a major expansion of its U.S....
Clinical

Phase 3 Firmonertinib Study Misses Primary Endpoint in EGFR Exon 20 NSCLC

ArriVent BioPharma reported that its phase 3 Furvent trial...
Insights

How Healthcare Organizations Are Building AI Centers of Excellence

   Executive Summary Artificial intelligence is moving from isolated healthcare experiments toward broader organizational adoption. Hospitals, health systems, pharmaceutical companies, insurers, and...
Insights

The Rise of Platform Biotech Companies

Executive Summary Biotechnology companies have traditionally been built around individual drug candidates, therapeutic programs, or specific biological targets. A different model...
Insights

Top 10 Emerging Modalities Beyond RNA Therapeutics

Executive Summary Pharmaceutical innovation is expanding beyond conventional small molecules and established biologics as researchers pursue new ways to address...
Manufacturing

FDA Warns Fresenius Kabi Over Manufacturing Deviations Linked to Famotidine Adverse Event Reports

The U.S. Food and Drug Administration (FDA) has issued...
Commercial

Novartis agrees to pay Abogen $7.8 billion for its in vivo autoimmune T-cell engager

Novartis-Abogen Deal & Background Novartis has agreed to pay Abogen...
Regulatory

Grail’s cancer blood test on the brink of receiving groundbreaking FDA approval

An advisory panel to the US Food and Drug Administration handed Grail's Galleri blood test a milestone win, saying...
Clinical

Pfizer Reports Phase 3 Results for Litfulo and Phase 2 Atopic Dermatitis Data for Tilrekimig

Pfizer has presented detailed results from two phase 3 clinical trials evaluating its oral Janus kinase (JAK) inhibitor Litfulo...
Insights

Top 10 ESG Priorities for Life Sciences Companies

Executive Summary Environmental, social, and governance (ESG) priorities are becoming increasingly integrated into how life sciences companies manage operations, supply...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration...
Editorial Team -
Clinical

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

MimiVax’s cancer vaccine failed to meet the primary endpoint...
Clinical

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Cerevance reported positive topline results from its Phase 3...
Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration...
Clinical

Zealand’s obesity medication fails once more in phase 3

Boehringer Ingelheim's survodutide drug has achieved the co-primary endpoints...

Research & Development

Market Access

Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...
Manufacturing

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Cerevance reported positive topline results from its Phase 3...
Editorial Team -